v2.3.0.15
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:  
Net income$ 29,173$ 26,238
Adjustments to reconcile net income to net cash provided by operating activities:  
Loss from discontinued operations activities, net of tax6463,169
Gain on sale of operations, net(2,832)(465)
Loss on redemption of convertible notes 1,996
Asset impairments 263
Depreciation and amortization expense15,10215,257
Amortization of discount on notes and deferred financing costs3,8053,985
Bad debt expense, net of recoveries4,1013,429
Adjustment to contingent earnout liability(1,152)(1,449)
Deferred income taxes(4,463)(1,226)
Employee stock awards4,4333,943
Excess tax benefits from share based payment arrangements(102)(77)
Changes in assets and liabilities, net of acquisitions and divestitures:  
Restricted cash(333)3,537
Accounts receivable, net(20,424)(29,617)
Other assets3,2023,599
Accounts payable(901)1,729
Income taxes payable/refundable7,4634,371
Accrued personnel costs and other liabilities5005,054
Net cash provided by continuing operations38,21843,736
Operating cash flows used in discontinued operations(641)(2,214)
Net cash provided by operating activities37,57741,522
Cash flows from investing activities:  
Business acquisitions and contingent consideration, net of cash acquired(25,727)(35,358)
Purchases of client fund investments(18,844)(2,975)
Proceeds from the sales and maturities of client fund investments9,1673,115
Proceeds from sales of divested and discontinued operations8381,265
Net decrease in funds held for clients17,06010,318
Additions to property and equipment, net(3,729)(2,055)
Other238
Net cash used in investing activities(21,212)(25,682)
Cash flows from financing activities:  
Proceeds from bank debt394,950425,125
Payment of bank debt(354,250)(416,125)
Proceeds from issuance of convertible notes 130,000
Repurchase of convertible notes(39,250)(60,000)
Payment for acquisition of treasury stock(7,987)(86,094)
Net decrease in client funds obligations(9,811)(10,458)
Proceeds from exercise of stock options7681,182
Payment of contingent consideration of acquisitions(330) 
Excess tax benefit from exercise of stock awards10277
Debt issuance costs(599)(6,068)
Other(149)(126)
Net cash used in financing activities(16,556)(22,487)
Net decrease in cash and cash equivalents(191)(6,647)
Cash and cash equivalents at beginning of year7247,178
Cash and cash equivalents at end of period$ 533$ 531